Viewing Study NCT01284192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-06 @ 1:13 AM
Study NCT ID: NCT01284192
Status: COMPLETED
Last Update Posted: 2016-06-28
First Post: 2011-01-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignancies View
None Positive for Anaplastic Lymphoma Kinase View
None Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS View
None Solid Tumor View
None B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell Lymphoma View
None Advanced Malignancies View
None Anaplastic Lymphoma Kinase (ALK) View
None ASP3026 View
None Solid Tumor View